Literature DB >> 26850990

The impact of gender, level of amputation and diabetes on prosthetic fit rates following major lower extremity amputation.

Fiona Davie-Smith1, Lorna Paul1, Natalie Nicholls2, Wesley P Stuart3, Brian Kennon3.   

Abstract

BACKGROUND: Diabetes mellitus is a leading cause of major lower extremity amputation.
OBJECTIVE: To examine the influence of gender, level of amputation and diabetes mellitus status on being fit with a prosthetic limb following lower extremity amputation for peripheral arterial disease. STUDY
DESIGN: Retrospective analysis of the Scottish Physiotherapy Amputee Research Group dataset.
RESULTS: Within the cohort with peripheral arterial disease ( n = 1735), 64% were men ( n = 1112) and 48% ( n = 834) had diabetes mellitus. Those with diabetes mellitus were younger than those without: mean 67.5 and 71.1 years, respectively ( p < 0.001). Trans-tibial amputation:trans-femoral amputation ratio was 2.33 in those with diabetes mellitus, and 0.93 in those without. A total of 41% of those with diabetes mellitus were successfully fit with a prosthetic limb compared to 38% of those without diabetes mellitus. Male gender positively predicted fitting with a prosthetic limb at both trans-tibial amputation ( p = 0.001) and trans-femoral amputation ( p = 0.001) levels. Bilateral amputations and increasing age were negative predictors of fitting with a prosthetic limb ( p < 0.001). Diabetes mellitus negatively predicted fitting with a prosthetic limb at trans-femoral amputation level ( p < 0.001). Mortality was 17% for the cohort, 22% when the amputation was at trans-femoral amputation level.
CONCLUSION: Of those with lower extremity amputation as a result of peripheral arterial disease, those with diabetes mellitus were younger, and more had trans-tibial amputation. Although both age and amputation level are good predictors of fitting with a prosthetic limb, successful limb fit rates were no better than those without diabetes mellitus. Clinical relevance This is of clinical relevance to those who are involved in the decision-making process of prosthetic fitting following major amputation for dysvascular and diabetes aetiologies.

Entities:  

Keywords:  Diabetes; prosthetics; rehabilitation

Mesh:

Year:  2016        PMID: 26850990      PMCID: PMC5302066          DOI: 10.1177/0309364616628341

Source DB:  PubMed          Journal:  Prosthet Orthot Int        ISSN: 0309-3646            Impact factor:   1.895


Background

Major lower extremity amputation is associated with significant morbidity and mortality. Worldwide, diabetes mellitus (DM) is the foremost cause of major lower extremity amputations,[1] and in the United Kingdom, DM accounts for 5–6000 major amputations each year.[2] Despite evidence that multi-disciplinary DM foot services reduce amputation rates,[3] a significant proportion of people with will undergo a major amputation. A recent study from Scotland found the major amputation rate to be 1.39 per 1000 persons with DM.[3] Given the socioeconomic burden, significant mortality and adverse impact on quality of life associated with major amputation,[4-6] optimising function post-operatively is of vital importance. Although DM has not been shown to influence survival rates in the immediate post-amputation period,[1,7] there is evidence that in the longer term the presence of DM reduces survival by almost 50% with a mean life expectancy of 27.2 months compared to 46.7 months in people with and without DM respectively.[8] DM has also been shown to double the likelihood of requiring a second or contralateral amputation.[1,9] Another important factor associated with life expectancy is the level of amputation.[10-12] Subramaniam et al.[13] reported the 30-day mortality following trans-femoral amputation (TFA) (18%) to be four times higher than that of trans-tibial amputation (TTA) (4%). Given the adverse impact that DM has on life expectancy following major amputation, it is important to optimise post-operative function both in terms of quality of life and cardiovascular fitness. Davis et al.[14] suggested that fitting with a prosthesis impacts significantly upon ambulation and subsequently improves quality of life. Despite the beneficial effect of being fit with a prosthetic limb, a retrospective study of major lower extremity amputations (LEAs) in a cohort of people with peripheral arterial disease (PAD) (almost half of whom had DM) demonstrated that only 45% of people ever achieve such an outcome.[15] Factors that affect the process of being fit with a prosthetic limb include pre-operative mobility, amputation level, age and the presence of coronary artery disease.[15-17] There is limited evidence examining the impact of DM on the chances of being successfully fit with a prosthetic limb post major amputation. The aim of this study was to examine the impact of DM, gender and the level of amputation on the rates of being fit with a prosthetic limb following non-traumatic major amputation in Scotland from 2007 to 2009, utilising data from the Scottish Physiotherapy Amputee Research Group (SPARG). Limb fitting rates were recorded up to discharge from rehabilitation services.

Materials and methods

This retrospective cohort study examined persons who underwent a non-traumatic major amputation, at TF and TT levels, in Scotland from 1 January 2007 to 31 December 2009. Ethical approval for the study was given by the College of Medical, Veterinary and Life Sciences (MVLS), Ethics Committee, University of Glasgow. The reason for amputation was PAD in the presence or absence of DM. Amputations due to tumour, trauma, congenital abnormality, orthopaedic complications or intra-venous drug use were excluded. Also excluded were amputations at the level of hip disarticulation, trans-pelvic, through knee and ankle disarticulation, as these were in small numbers and have specific requirements for rehabilitation and prosthetic manufacture. Major LEA was defined as a complete loss of the limb in the transverse anatomical plane proximal to the ankle.[18] The final recorded level of amputation was taken as the most proximal, capturing those who underwent revisions to a higher level. If a person underwent bilateral amputation within the 3-year period, this was also recorded. The presence of DM at the time of major amputation was confirmed from the medical notes but not categorised further. Data were extracted from the SPARG dataset. SPARG is a network of physiotherapists with clinical responsibility for people with a major amputation in all the health boards of Scotland. Anonymised data have been prospectively collected from all people undergoing major amputation in Scotland since 1991. The dataset consists of demographics, rehabilitation milestones and limb fitting outcomes.[19] Data were collected from the time of amputation until discharge from the rehabilitation service. This included out-patient treatment. The following variables were extracted from the SPARG database: gender, age, DM status, Functional Co-Morbidity Index (FCI) (an 18-point tool that measures presence of co-morbidities)[20] at time of amputation, date of amputation, primary indication for amputation (underlying pathology), the level and side of amputation, number of previous amputations, length of in-patient and out-patient treatment, discharge destination, dates and final outcome at the end of the rehabilitation process. Final outcomes were categorised as follows: limb fit (LF) (discharged from rehabilitation using a prosthesis), non-limb fit (NLF) (did not start the limb fitting process), abandoned (commenced the prosthetic process and then stopped prior to discharge from rehabilitation) or died (death during the rehabilitation process). Descriptive statistics were undertaken for the total dataset, and then specifically for those with and without DM. Chi-squared tests of association were used for comparison between populations; a binary logistic model was used to determine the likelihood of being fit with a prosthetic limb following a TT or TFA. All analysis was performed using Minitab v15 and R software packages, with a significance level of 5%.

Results

There were 2145 major amputations performed in Scotland between 1 January 2007 and 31 December 2009. In 331 cases, the major amputation was due to tumour, trauma, congenital abnormalities, orthopaedic complications or intra-venous drug use and these were excluded from further analysis. Amputations at hip disarticulation level (n = 17), trans-pelvic (n = 2) and ankle disarticulation (n = 4) were also excluded. Forty-four people underwent knee-disarticulation amputations over the 3 years, and of these, 12 people had DM and 26 did not. This group was also excluded from further analysis because they represented a small portion of the cohort (3%) and had quite specific characteristics and requirements for both rehabilitation and prosthetic manufacture. A total of 1747 people underwent amputations at TT and TF levels. In 12 cases (<1%), data were incomplete leaving 1735 cases for analysis. The cohort consisted of 64% men (n = 1112) and 36% women (n = 623). Of the total cohort, 48% (n = 834) had DM, of which 70% (n = 582) were men and 30% (n = 252) women. This compared to 59% (n = 530) men and 41% (n = 371) women in those without DM. The mean age at amputation was 69.7 years (standard deviation (SD) = 12.3). Those with DM were significantly younger (mean = 67.5 years) than those without DM (mean = 71.1 years) (p < 0.001); this was true for both men and women (both p < 0.001) (Table 1).
Table 1.

Total cohort gender, diabetes status and age.

Non-diabetes, n (%)Diabetes, n (%)p-value
Gender
 Total901 (52)834 (48)
 Men530 (59)582 (70)< 0.001
 Women371 (41)252 (30)< 0.001
 M/W ratio1.432.31
Level
 Bilateral150 (17)214 (26)< 0.001
 TTA362 (40)434 (52)< 0.001
 TFA389 (43)186 (22)< 0.001
 TTA/TFA ratio0.932.33
Mean age (years)71.167.5< 0.001
 Men, mean age (SD)70.6 (11)67.4 (11)< 0.001
 Women, mean age (SD)73.6 (11)68.7 (13)< 0.001

M/W: men/women; TTA: trans-tibial amputation; TFA: trans-femoral amputation; SD: standard deviation.

Total cohort gender, diabetes status and age. M/W: men/women; TTA: trans-tibial amputation; TFA: trans-femoral amputation; SD: standard deviation. In terms of co-morbidities, FCI scores were generally low (mean = 3.2, SD = 1.9). Scores were similar between men (mean = 3.3) and women (mean = 3.4) and between those with and without DM (mean = 3.8 and 2.9), respectively. In the overall cohort, 79% (n = 1371) had a unilateral amputation, of these 58% (n = 796) were TTA and 42% (n = 575) were TFA. There was a significantly greater proportion of people with a TTA in the cohort with DM (p < 0.001) (Table 1). The people with DM were therefore younger and more likely to have TTAs. Overall, 38% (n = 659) of the cohort were fit with a prosthetic limb. This did not include the group that started but abandoned the process (3%). Overall, 72% (n = 477) of those who underwent TTA were fit with a prosthetic limb compared to 16% who underwent TFA (n = 94). Twenty-four percent (n = 88) of people with bilateral amputations were fit with prosthetic limbs, which is a significantly lower proportion than those with a unilateral amputation (42%, n = 571) (p < 0.001). In relation to bilateral amputation, the level also impacted on being fit with a prosthetic limb as those with bilateral TFAs were significantly less likely to be fit with prosthetic limbs compared to those with bilateral TTAs (p < 0.001) (Table 2).
Table 2.

Final limb fit outcomes of people with bilateral amputations.

Bilateral level combinationLimb fit, n (%)Non-limb fit, n (%)Abandoned, n (%)Died[a], n (%)
Bilateral TTA (n = 196)87 (44)74 (38)8 (4)27 (14)
TTA + TFA (n = 14)1 (7)6 (43)3 (21)4 (29)
Bilateral TFA (n = 154)0 (0)119 (77)0 (0)35 (23)
Total (n = 364)88 (24)199 (55)11 (3)66 (18)

TTA: trans-tibial amputation; TFA: trans-femoral amputation.

Died within the rehabilitation period.

Final limb fit outcomes of people with bilateral amputations. TTA: trans-tibial amputation; TFA: trans-femoral amputation. Died within the rehabilitation period. In terms of gender, for both TTA and TFA, significantly more men than women were fit with a prosthetic limb (TTA: men = 341 (63%), women = 136 (53%); TFA: men = 65 (21%), women = 29 (11%) (p = 0.001)). Gender had no impact on those who abandoned the prosthetic fitting process (Table 3).
Table 3.

Influence of gender on limb fit depending on amputation level.

TotalLimb fit, n (%)Non-limb fit, n (%)Abandoned, n (%)Died[a], n (%)
TTATotal796477 (60)200 (25)22 (3)97 (12)
Male538341 (63)119 (22)15 (3)63 (12)
Female258136 (53)81 (31)7 (3)34 (13)
TFATotal57594 (16)342 (60)11 (2)128 (22)
Male30465 (21)176 (58)6 (2)57 (19)
Female27129 (11)166 (61)5 (2)71 (26)
BilateralTotal36488 (24)199 (55)11 (3)66 (18)
Male25669 (27)133 (52)8 (3)46 (18)
Female10819 (17)66 (61)3 (3)20 (19)

TTA: trans-tibial amputation; TFA: trans-femoral amputation.

Died within the rehabilitation period.

Influence of gender on limb fit depending on amputation level. TTA: trans-tibial amputation; TFA: trans-femoral amputation. Died within the rehabilitation period. The mortality rate within the rehabilitation period was 17% (n = 291); 16% for those with DM and 17% for those without DM. This rate was higher following bilateral amputation (18.1%) and unilateral TFA (22%) compared to unilateral TTA (12%) (Table 3). Thirty-day mortality was 7% (n = 114), of which 22% (n = 25) had bilateral amputations and 78% (n = 89) had unilateral amputations. Furthermore, 43% had DM compared to 57% without DM. The 30-day mortality was 50% in those with bilateral amputation who had one TTA and one TFA and, of these, 75% had DM. In those with bilateral TFAs, 51% died within 30 days and 50% of those had DM. In comparison, 19% of those with bilateral TTAs died within 30 days and all had DM. Within the cohort, 48% had DM (n = 834), and of those 41% (n = 346) were fit with a prosthetic limb. With respect to those who underwent TTA, similar proportions of those with and without a diagnosis of DM were fit with a prosthetic limb (44% and 56%, respectively; p = 0.399). By comparison, only 16% of people who underwent a TFA proceeded to fit with a prosthetic limb. Of these, significantly fewer people with DM (n = 14, 8%) were fit with a prosthetic limb compared to those without DM (n = 80, 21%) (p < 0.001). In the group with DM, bilateral amputations were significantly more frequent (n = 214) compared to those without DM (n = 150) (p < 0.001). Additionally, there were more bilateral TTAs compared to bilateral TFAs within the group with DM but this difference was not significant (p = 0.070). For those with DM, significantly more men underwent bilateral amputations than women (p = 0.009). There was no significant difference in mortality between those with and without DM (p = 0.535) (Table 4).
Table 4.

Influence of diabetes status on limb fitting depending on amputation level.

TotalLimb fit, n (%)Non-limb fit, n (%)Abandoned, n (%)Died[a], n (%)
TTATotal796477 (60)200 (25)22 (3)97 (12)
Non-DM362209 (58)97 (27)11 (3)45 (12)
DM434268 (62)103 (24)11 (3)52 (12)
TFATotal57594 (16)342 (60)11 (2)128 (22)
Non-DM38980 (21)219 (56)8 (2)82 (21)
DM18614 (8)123 (66)3 (2)46 (25)
BilateralTotal36488 (24)199 (55)11 (3)66 (18)
Non-DM15024 (16)92 (61)6 (4)28 (19)
DM21464 (30)107 (50)5 (2)38 (18)

TTA: trans-tibial amputation; DM: diabetes mellitus; TFA: trans-femoral amputation.

Died within the rehabilitation period.

Influence of diabetes status on limb fitting depending on amputation level. TTA: trans-tibial amputation; DM: diabetes mellitus; TFA: trans-femoral amputation. Died within the rehabilitation period. A binary logistic regression model was used to predict which characteristics correlated with the likelihood of being fit with a prosthetic limb following TTA and TFA. Those who had died were excluded, and the outcomes were dichotomised to those who were and those who were not fit with a prosthetic limb (those who abandoned fitting with a prosthesis were included in the latter category for this analysis). The small number of cases who underwent a TTA on one side and a TFA on the other (n = 10) were excluded from the analysis. Men were significantly more likely to fit with a prosthesis than women following both TTA (odds ratio (OR) = 1.71, 95% confidence interval (CI) = 1.24–2.36, p < 0.001) and TFA (OR = 2.17, 95% CI = 1.36–3.47, p = 0.001). The presence of DM did not predict who were fit with a prosthesis in those who underwent a TTA (OR = 1.14, 95% CI = 0.84–1.56, p = 0.399), but for those who underwent a TFA having DM negatively influenced the probability of being fit with a prosthetic limb (OR = 0.35, 95% CI = 0.20–0.61, p < 0.001). Increasing age was also a negative predictor of prosthetic fitting after both TTA and TFA; for each year increase in age, there was a 3% reduction in the likelihood of fitting with a prosthesis ((TTA: OR = 0.97, 95% CI = 0.96–0.98, p < 0.001) and (TFA: OR = 0.97, 95% CI = 0.95–0.97, p < 0.001)). The mean length of rehabilitation was 126 days (range = 84–184 days) following major amputation (men: 127 days, SD = 109; women: 125 days, SD = 118) with no significant differences between those with and those without DM (p = 0.462). Similarly, the level of amputation did not seem to influence the duration of rehabilitation (p = 0.547). Those who were fit with a prosthetic limb had, on average, 100 more days of rehabilitation than those who were not fit with a prosthesis (p < 0.001). For those who were fit with a prosthetic limb, women had a significantly longer rehabilitation period (136.7 days) than men (116 days) by an average of 3 weeks (p < 0.010). Similar proportions of people with DM were discharged to their home (80%) compared to those without DM (81%) (p = 0.248).

Discussion

We believe this is the first study to report national prospectively collected data on those who were fit with a prosthetic limb following non-traumatic, major LEA at the TT and TF levels. Within this study, 48% had DM, which is similar to rates reported elsewhere[4,10,15,21] and specifically in Italy where 49% of those undergoing major LEA had DM[22] and lower than Spain where 57% of those undergoing major LEA had DM.[23] Those with DM were more likely to undergo TTA (52%) compared to those without DM (40%).[24] This is probably due to diabetes-related distal arterial disease below the knee with relative sparing of the proximal vessels.[25] Although the rates of successful fitting with a prosthetic limb were no different between those with and without DM, our data demonstrate that people with DM who have a major amputation are younger and more likely to have a TTA compared to those without DM. Both factors are regarded as favourable predictors of being successfully fit with a prosthetic limb.[15-17,26,27] Gender is known to influence major amputation rates and, as in previous studies,[7,10,15,28,29] we found that major amputation was significantly more common in men. This effect of gender was seen following both TTA and TFA. The gender difference was more pronounced in the group with DM, with men:women ratio of 2.31 compared to 1.43 in those without. The higher amputation rates in men may be due to more severe PAD in men than in women.[23] Furthermore, higher smoking rates in men may be a contributing factor.[30] Others have suggested that the presence of oestrogen, which improves wound healing, may explain the relatively lower rates of major amputations in women.[30] We have also shown that gender influences the chances of successful fitting with a prosthetic limb with more men likely to be fit with a prosthesis than women. Women are more commonly affected by specific co-morbidities such as coronary heart disease and stroke[31,32] which may explain the lower LF rates in women observed in this study. Although the FCI scores were similar in men and women, we did not investigate the relationship between any specific co-morbidity and limb fitting rates. The reasons for the gender difference in amputations and LF rates merit further investigation. The overall percentage of those being fitted with a prosthetic limb was 38%. This is lower than previous studies which demonstrated limb fitting figures of 45%–55%.[15,16] This discrepancy is partly explained by the fact that our study analysed both unilateral and bilateral TTA and TFA levels, whereas previous studies have generally focussed on unilateral amputations.[24,27] In this study, 42% of those with a unilateral amputation were fit with a prosthesis. As demonstrated previously, the level of amputation significantly influenced the likelihood of being fit with a prosthesis.[15,16,24,26] People undergoing a TTA are more likely to be fit with a prosthetic limb compared to those with a TFA. This may be related to the reduced energy expenditure required to walk with a TT prosthesis[26] or may be due to other factors such as pre-amputation mobility and cognitive status.[15-17] A TF prosthesis can be less comfortable to wear but also requires a higher level of cognitive function to benefit from the varying knee components.[33] Only 16% of people were fit with a prosthesis following TFA. A novel finding from the study was the significantly negative impact that DM had on successfully being fitted with a limb specifically following TFA (OR = 0.35). It is likely that complications associated with DM such as obesity, cardiovascular disease, contralateral foot problems, poor balance, poor wound healing and renal insufficiency may explain this finding. Receiving bilateral amputations has been shown to significantly reduce the likelihood of being fit with a prosthesis and subsequently achieving mobility.[16] From our study, if a person has bilateral amputations with one at TF level, then they are far less likely to proceed to being fit with a prosthetic limb compared to those with bilateral TTA (Table 5). Also within our study, only 3% of people abandoned the prosthetic fitting process, suggesting that the decision to proceed to being fit with a prosthesis is generally appropriate.
Table 5.

Predictors of limb fit post major amputation.

CharacteristicOdds ratio (95% CI)p-value
TTA
 Men1.71 (1.24–2.36)< 0.001
 Diabetes1.14 (0.84–1.56)0.399
 Bilateral0.33 (0.23–0.47)< 0.001
 Age0.97 (0.96–0.98)< 0.001
TFA
 Men2.17 (1.36–3.47)< 0.001
 Diabetes0.35 (0.20–0.61)< 0.001
 Bilateral0.06 (0.02–0.20)< 0.001
 Age0.97 (0.95–0.97)< 0.001

CI: confidence interval; TTA: trans-tibial amputation; TFA: trans-femoral amputation.

Predictors of limb fit post major amputation. CI: confidence interval; TTA: trans-tibial amputation; TFA: trans-femoral amputation. The mean age of the entire cohort at time of amputation was 69.7 years. Those with DM were on average 4 years younger, with no significant differences in ages between genders. Similar age differences have been shown in populations of people with amputations in other studies in the United Kingdom,[6] Greece[1] and Denmark.[34] As previously stated, despite persons with DM being younger and with more TTAs, they were no more likely to be successfully fit with a prosthetic limb. We found that those who were fit with a prosthetic limb spent a longer time in rehabilitation. This is to be expected as prosthetic fitting in itself warrants more physiotherapy input.[1,16] The finding that women spent longer in rehabilitation whether they were fit with a prosthetic limb or not was novel and is another area that warrants further investigation. The overall mortality rate within the rehabilitation period was 17%. Previous studies tend to quote 30-day mortality which was 7% in this study, slightly lower than reported in other series at 10%.[11,15,35] In agreement with other studies, gender and DM status did not influence mortality; however, those with unilateral or bilateral TFAs had higher mortality rates.[15,34] Subramaniam et al.[13] report a TFA as a high cardiac risk surgery compared to a TTA as intermediate risk, with mortality rates of 17.5% and 4.2%, respectively. One of the main strengths of our study is the large and comprehensive nature of the cohort, and by assessing national data we reduce the impact of regional bias and variation in practice within individual units.[29] However, the use of secondary data analysis has a number of limitations. No cause and effect relationship can be determined between the variables. In addition, we were unable to assess other factors that may influence the ability to successfully fit with a prosthetic limb, such as pre-amputation limb salvaging surgery and cognition[15-17] as these data are not recorded within the SPARG database. In terms of other limitations, the study only included data from those with TTA and TFA levels of amputation, and included data were recorded only up to the end of the rehabilitation period, on average 4 months from amputation, thus considering only short-term outcomes. Being fit with a prosthetic limb was the only outcome assessed in this study, and future research should consider function, mobility and, importantly, quality of life as specific outcomes. In conclusion, our large national study of limb fitting rates following major amputation has reinforced previous findings and highlighted more novel aspects related to gender and DM status. Further longitudinal, prospective research is required to investigate factors that influence post-amputation limb fitting rates in persons with DM and in particular women as this will dictate the requirements of clinical services in optimising both the short- and long-term future for this population.
  33 in total

1.  Mobility outcome following unilateral lower limb amputation.

Authors:  B Davies; D Datta
Journal:  Prosthet Orthot Int       Date:  2003-12       Impact factor: 1.895

Review 2.  Predicting walking ability following lower limb amputation: a systematic review of the literature.

Authors:  Kate Sansam; Vera Neumann; Rory O'Connor; Bipin Bhakta
Journal:  J Rehabil Med       Date:  2009-07       Impact factor: 2.912

3.  Assessing the long-term outcomes of minor lower limb amputations: a 5-year study.

Authors:  Mohammed Mohsin Uzzaman; Saud Jukaku; Amir Kambal; Syed Tahir Hussain
Journal:  Angiology       Date:  2011-03-18       Impact factor: 3.619

4.  Mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes.

Authors:  Christopher J Schofield; Gillian Libby; Geraldine M Brennan; Ritchie R MacAlpine; Andrew D Morris; Graham P Leese
Journal:  Diabetes Care       Date:  2006-10       Impact factor: 19.112

5.  Survival after lower-extremity amputation.

Authors:  Diana Kovacich Sandnes; Michael Sobel; David Reed Flum
Journal:  J Am Coll Surg       Date:  2004-09       Impact factor: 6.113

6.  Prosthetic use in elderly patients with dysvascular above-knee and through-knee amputations.

Authors:  C E Beekman; L A Axtell
Journal:  Phys Ther       Date:  1987-10

Review 7.  Lower-extremity amputations in patients with diabetes: pre- and post-surgical decisions related to successful rehabilitation.

Authors:  Brian L Davis; Jennifer Kuznicki; S Solomon Praveen; James J Sferra
Journal:  Diabetes Metab Res Rev       Date:  2004 May-Jun       Impact factor: 4.876

8.  Reduced incidence of lower-extremity amputations in people with diabetes in Scotland: a nationwide study.

Authors:  Brian Kennon; Graham P Leese; Lynda Cochrane; Helen Colhoun; Sarah Wild; Duncan Stang; Naveed Sattar; Donald Pearson; Robert S Lindsay; Andrew D Morris; Shona Livingstone; Matthew Young; John McKnight; Scott Cunningham
Journal:  Diabetes Care       Date:  2012-09-25       Impact factor: 19.112

9.  Lower extremity amputations in persons with and without diabetes in Italy: 2001-2010.

Authors:  Flavia L Lombardo; Marina Maggini; Alessandra De Bellis; Giuseppe Seghieri; Roberto Anichini
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

10.  Risks of nontraumatic lower-extremity amputations in patients with type 1 diabetes: a population-based cohort study in Sweden.

Authors:  Junmei Miao Jonasson; Weimin Ye; Pär Sparén; Jan Apelqvist; Olof Nyrén; Kerstin Brismar
Journal:  Diabetes Care       Date:  2008-04-28       Impact factor: 19.112

View more
  8 in total

1.  The Kenevo microprocessor-controlled prosthetic knee compared with non-microprocessor-controlled knees in individuals older than 65 years in Sweden: A cost-effectiveness and budget-impact analysis.

Authors:  Alexander Kuhlmann; Kerstin Hagberg; Ilka Kamrad; Nerrolyn Ramstrand; Susanne Seidinger; Hans Berg
Journal:  Prosthet Orthot Int       Date:  2022-05-03       Impact factor: 1.672

2.  Deleterious Musculoskeletal Conditions Secondary to Lower Limb Loss: Considerations for Prosthesis-Related Factors.

Authors:  Ashley D Knight; Christopher L Dearth; Brad D Hendershot
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-05-22       Impact factor: 4.730

3.  Adults with unilateral lower-limb amputation: greater spatial extent of pain is associated with worse adjustment, greater activity restrictions, and less prosthesis satisfaction.

Authors:  Jaclyn Megan Sions; Emma Haldane Beisheim-Ryan; Ryan Todd Pohlig; Mayank Seth
Journal:  Scand J Pain       Date:  2022-02-01

4.  Factors Associated With Prolonged Length of Stay and Failed Lower Limb Prosthetic Fitting During Inpatient Rehabilitation.

Authors:  Michael Chislett; Michelle Ploughman; Jason McCarthy
Journal:  Arch Rehabil Res Clin Transl       Date:  2020-09-19

5.  SwedeAmp-the Swedish Amputation and Prosthetics Registry: 8-year data on 5762 patients with lower limb amputation show sex differences in amputation level and in patient-reported outcome.

Authors:  Ilka Kamrad; Bengt Söderberg; Hedvig Örneholm; Kerstin Hagberg
Journal:  Acta Orthop       Date:  2020-04-22       Impact factor: 3.717

6.  Suitability of 'Guidelines for Screening of Prosthetic Candidates: Lower Limb' for the Eastern Cape, South Africa: A qualitative study.

Authors:  Luphiwo L Mduzana; Surona Visagie; Gubela Mji
Journal:  S Afr J Physiother       Date:  2018-01-30

7.  Cost-effectiveness and budget impact of the microprocessor-controlled knee C-Leg in transfemoral amputees with and without diabetes mellitus.

Authors:  Alexander Kuhlmann; Henning Krüger; Susanne Seidinger; Andreas Hahn
Journal:  Eur J Health Econ       Date:  2020-01-02

8.  Quantifying Step Count and Oxygen Consumption with Portable Technology during the 2-Min Walk Test in People with Lower Limb Amputation.

Authors:  John D Smith; Gary Guerra
Journal:  Sensors (Basel)       Date:  2021-03-16       Impact factor: 3.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.